Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
12 Results Found
FDA approves first-in-class non-opioid painkiller
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to severe acute pain in adults.
CMMI releases 2024 Report to Congress
The Center for Medicare and Medicaid Innovation yesterday released its 2024 Report to C
CMS announces two drug manufacturers to participate in CGT Access Model
The Centers for Medicare & Medicaid Services Dec. 4 announced that drug manufacturers bluebird bio, inc. (manufacturer of Lyfgenia) and Vertex Pharmaceuticals (manufacturer of Casgevy) will participate in its Cell and Gene Therapy Access Model.
CMS report finds hospital-at-home program safe, effective
The Centers for Medicare & Medicaid Services Sept. 30 released a report on the hospital-at-home program, which found that patients and caregivers overall had positive experiences in the program.
House Energy and Commerce Committee advances two-year telehealth extension, extends hospital-at-home program to 2029
The House Energy and Commerce Committee Sept. 18 advanced legislation on expiring telehealth and hospital-at-home flexibilities. The AHA supported the passage of the Telehealth Modernization Act, which extended telehealth flexibilities for two years that are set to expire Dec. 31 and included a five-year extension of the hospital-at-home program.
Two AdventHealth hospitals receive ASHRM 2024 Innovation Award
The American Society for Health Care Risk Management Sept. 5 announced two AdventHealth hospitals in Florida will receive its 2024 Innovation Award. AdventHealth Dade City and AdventHealth Zephyrhills are being recognized for the success of their falls prevention program.
House Energy and Commerce Health Subcommittee holds hearing on value-based care
The House Energy and Commerce Health Subcommittee June 13 held a hearing about transitioning to value-based care. The AHA submitted a statement to the subcommittee for the hearing, expressing support for value-based care and sharing principles the Center for Medicare and Medicaid Innovation should consider when designing alternative payment models.
Congress introduces legislation to extend hospital-at-home program
The AHA praised Congress May 23 for their support and introduction of the bipartisan Hospital Inpatient Services Modernization Act, which would grant a five-year extension to the hospital-at-home program.
AHA urges Congress to extend Affordable Connectivity Program to support digital health care services
In a letter submitted May 7 to a bipartisan group of senators, AHA urged Congress to extend the Affordable Connectivity Program, which provides benefits toward high-speed internet, allowing patients access to services such as telehealth, hospital at home, patient portals and electronic patient records, virtual scheduling and remote patient monitoring.
AHA comments on draft legislation to extend hospital-at-home program
Commenting last week on a discussion draft of the Hospital Inpatient Services Modernization Act, which would extend the hospital-at-home program through 2027, AHA thanked the sponsors for their ongoing work to extend this innovative program and voiced support for its continuance.